September 2024
1. TANAKA A, Ma X, Takahashi A, Vierling JM, et al
   Primary biliary cholangitis.
   Lancet. 2024;404:1053-1066.
   

   >> Share

   
   April 2023
2. SLATER S, Cunningham D
   Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer.
   Lancet. 2023 Apr 14:S0140-6736(23)00767-5. doi: 10.1016/S0140-6736(23)00767.
   

   >> Share

   
   
3. KELLEY RK, Ueno M, Yoo C, Finn RS, et al
   Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2023 Apr 14:S0140-6736(23)00727-4. doi: 10.1016/S0140-6736(23)00727.
   

   >> Share

   
   March 2023
4. ZAROCOSTAS J
   Global health experts welcome Kasai dismissal.
   Lancet. 2023;401:890.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share